Hepatitis was correctly predicted in 5 of 6 CMV IgG+ CD4+ TEM≥16% melanoma patients, which corresponds to a PPV of 83% and NPV of 80% (Figure 6F). This evidence concerns the gene CD4 and Hepatitis.